Moderna
-
Health Canada approves Moderna’s combined COVID, flu shot for someBoth of the vaccines are only approved for Canadians aged 50 and older, and it's not clear yet when they might be available to get at your pharmacy.HealthNov 6
-
Moderna’s experimental mRNA cancer treatment progresses, shares spikeModerna and Merck are developing a treatment using an mRNA-based cancer vaccine designed to be tailored to individual patients based on unique mutations within their tumors.HealthAug 19
-
-
Advertisement
-
FDA approves Moderna’s mRNA-based vaccine for the fluThe shot, named mFlusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.U.S. NewsAug 6
-
-
Advertisement
-
Still ‘many steps to do’ in creating a hantavirus vaccine, experts sayFour Canadians are isolating across the country after exposure on the hantavirus-hit MV Hondius cruise ship. The outbreak has left three dead and 11 other identified cases.HealthMay 13
-
Moderna’s latest COVID-19 vaccine is both approved and ‘made in Canada’An update to Moderna's COVID-19 vaccine that targets the newest variants and is made entirely within Canada's borders was just approved by Health Canada.HealthAug 25, 2025
-
-
Moderna pulls application for U.S. approval of COVID-flu shotModerna's decision comes a day after the FDA said it would require new clinical trials for approval of annual COVID-19 boosters for healthy people under 65.HealthMay 21, 2025
-
-
Canada approves Moderna’s RSV vaccine, first of its kind for older adultsHealth Canada has approved the vaccine, mRESVIA, for the prevention of lower respiratory tract disease in older adults, the company said.HealthNov 8, 2024
-
COVID-flu shot offers strong immune response in late-stage trial, Moderna saysModerna says it combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults 50 and over when compared to separate shots.HealthJun 10, 2024
-
-
Advertisement
-
Moderna forecasts weaker sales as COVID vaccine demand wanesModerna said on Thursday its 2023 sales would only hit the low end of its previous forecast, reflecting weaker demand for COVID-19 vaccines.HealthNov 2, 2023
-
-
Advertisement
-
Moderna can meet 2023 COVID vaccine forecast, unlike Pfizer: analystsAround 20 million people need to be vaccinated with Moderna's updated COVID-19 vaccine for the company to reach US$2 billion in 2023 sales.WorldNov 1, 2023
Trending
-
-
Norway says it has been bumped for Russia to compete at world juniors in Canada
16,304 READ -
‘I love our country’ Nvidia CEO regrets affair with alleged China spy
13,361 READ -
Russell Brand sentenced to more than 10 years in prison
12,710 READ -
15 soldiers on ventilators, 9 critical after deadly CFB Wainwright fire
11,057 READ
Top Videos
-
Peterborough university, high school students protest changes to OSAP -
Peterborough musicians support cancer care with “Cancer Takedown” concert -
Remembrance Day ceremony held in Bridgenorth -
Peterborough residents, Petes kick off Movember campaigns -
Turning back the clock can impact driver safety, our biological clocks -
Global Peterborough’s Business Beat Nov. 2 -